Page last updated: 2024-11-04

rofecoxib and Pelvic Pain

rofecoxib has been researched along with Pelvic Pain in 3 studies

Pelvic Pain: Pain in the pelvic region of genital and non-genital origin.

Research Excerpts

ExcerptRelevanceReference
"We determine the effects of treatment with rofecoxib and placebo in patients with chronic prostatitis."9.10A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. ( Bach, M; Drisko, J; Farrington, J; Gittelman, M; Krupa, D; Malek, G; Moon, T; Nickel, JC; Pearson, J; Pontari, M, 2003)
"We determine the effects of treatment with rofecoxib and placebo in patients with chronic prostatitis."5.10A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. ( Bach, M; Drisko, J; Farrington, J; Gittelman, M; Krupa, D; Malek, G; Moon, T; Nickel, JC; Pearson, J; Pontari, M, 2003)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nickel, JC1
Pontari, M1
Moon, T1
Gittelman, M1
Malek, G1
Farrington, J1
Pearson, J1
Krupa, D1
Bach, M1
Drisko, J1
Cobellis, L1
Razzi, S1
De Simone, S1
Sartini, A1
Fava, A1
Danero, S1
Gioffrè, W1
Mazzini, M1
Petraglia, F1
Dimitrakov, JD1
Kaplan, SA1
Kroenke, K1
Jackson, JL1
Freeman, MR1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Genetic Studies of Urologic Chronic Pelvic Pain Syndrome[NCT00675298]300 participants (Anticipated)Observational2006-01-31Completed
Diagnostic Challenges in IC (and Male CPPS)[NCT00672087]1,000 participants (Anticipated)Observational2003-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for rofecoxib and Pelvic Pain

ArticleYear
Management of chronic prostatitis/chronic pelvic pain syndrome: an evidence-based approach.
    Urology, 2006, Volume: 67, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal;

2006
Management of chronic prostatitis/chronic pelvic pain syndrome: an evidence-based approach.
    Urology, 2006, Volume: 67, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal;

2006
Management of chronic prostatitis/chronic pelvic pain syndrome: an evidence-based approach.
    Urology, 2006, Volume: 67, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal;

2006
Management of chronic prostatitis/chronic pelvic pain syndrome: an evidence-based approach.
    Urology, 2006, Volume: 67, Issue:5

    Topics: Adrenergic alpha-Antagonists; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal;

2006

Trials

2 trials available for rofecoxib and Pelvic Pain

ArticleYear
A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.
    The Journal of urology, 2003, Volume: 169, Issue:4

    Topics: Adult; Aged; Chronic Disease; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Double-

2003
The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis.
    European journal of obstetrics, gynecology, and reproductive biology, 2004, Sep-10, Volume: 116, Issue:1

    Topics: Adult; Cyclooxygenase Inhibitors; Double-Blind Method; Endometriosis; Female; Gynecologic Surgical P

2004